July 19, 2018

Tendyne Holdings, Inc. Securityholder's Representative Committee v. Abbott Vascular, Inc. et al.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 20, 2020

    Abbott Can't Nix Suit Over Losing Out On $50M Merger Bonus

    A Delaware federal judge on Thursday rejected Abbott Laboratories' bid to dismiss a suit by former stockholders of Tendyne Holdings Inc. claiming that a merger contract breach cost them $50 million, ruling the amended complaint alleges enough facts to keep the suit alive that the original complaint lacked.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!